ATE30589T1 - Ester von cyproheptadin-3-carbonsaeure und verbindungen, die eine aehnliche struktur aufweisen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents

Ester von cyproheptadin-3-carbonsaeure und verbindungen, die eine aehnliche struktur aufweisen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE30589T1
ATE30589T1 AT83103380T AT83103380T ATE30589T1 AT E30589 T1 ATE30589 T1 AT E30589T1 AT 83103380 T AT83103380 T AT 83103380T AT 83103380 T AT83103380 T AT 83103380T AT E30589 T1 ATE30589 T1 AT E30589T1
Authority
AT
Austria
Prior art keywords
emesis
esters
dyspepsia
cyproheptadine
compounds
Prior art date
Application number
AT83103380T
Other languages
English (en)
Inventor
David C Remy
Bradley V Clineschmidt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE30589T1 publication Critical patent/ATE30589T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT83103380T 1982-04-14 1983-04-07 Ester von cyproheptadin-3-carbonsaeure und verbindungen, die eine aehnliche struktur aufweisen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. ATE30589T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/368,257 US4412999A (en) 1982-04-14 1982-04-14 Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds
EP83103380A EP0092114B1 (de) 1982-04-14 1983-04-07 Ester von Cyproheptadin-3-carbonsäure und Verbindungen, die eine ähnliche Struktur aufweisen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE30589T1 true ATE30589T1 (de) 1987-11-15

Family

ID=23450498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83103380T ATE30589T1 (de) 1982-04-14 1983-04-07 Ester von cyproheptadin-3-carbonsaeure und verbindungen, die eine aehnliche struktur aufweisen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Country Status (16)

Country Link
US (1) US4412999A (de)
EP (1) EP0092114B1 (de)
JP (1) JPS58188879A (de)
KR (1) KR880002042B1 (de)
AT (1) ATE30589T1 (de)
AU (1) AU556530B2 (de)
CA (1) CA1203798A (de)
DE (1) DE3374312D1 (de)
DK (1) DK161983A (de)
ES (1) ES521359A0 (de)
GR (1) GR78832B (de)
IE (1) IE55033B1 (de)
IL (1) IL68306A (de)
NZ (1) NZ203786A (de)
PT (1) PT76501B (de)
ZA (1) ZA832589B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522821A (en) * 1982-04-14 1985-06-11 Merck & Co., Inc. Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds
US4501749A (en) * 1983-10-31 1985-02-26 Merck & Co., Inc. Peripherally selective dopamine antagonists in the treatment of ocular hypertension
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
CA2025398A1 (en) * 1989-09-20 1992-03-15 Timothy Gerard Dinan Diagnosis and treatment of a disorder of the gastrointestinal tract
FR2877573B1 (fr) * 2004-11-05 2007-02-02 Debussy Holding Sa Nouvelles compositions pharmaceutiques et leurs utilisations pour lutter contre les differentes formes d'accoutumance aux drogues
EP2067777B1 (de) * 2006-09-29 2013-08-14 Nippon Zoki Pharmaceutical Co., Ltd. Oxepinderivat
ES2955693T3 (es) 2012-12-24 2023-12-05 Neurogastrx Inc Métodos para el tratamiento de trastornos del tracto GI
US9844554B2 (en) 2014-06-24 2017-12-19 Neurogastrx, Inc. Prodrugs of metopimazine
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3014911A (en) * 1958-09-29 1961-12-26 Merck & Co Inc Derivatives of dibenzo[a, e]cycloheptatriene
NL125839C (de) * 1963-12-03
US3981877A (en) * 1972-08-14 1976-09-21 Merck & Co., Inc. Piperidylidene derivatives of carboxy-5H-dibenzo[a,d]cycloheptene
US4072756A (en) * 1973-05-17 1978-02-07 Sandoz Ltd. Tricyclo piperidino ketones and soporific compositions thereof
US4086350A (en) * 1974-11-06 1978-04-25 Smithkline Corporation Pharmaceutical compositions and method of producing anti-psychotic activity without extrapyramidal symptoms
NL173398C (nl) * 1974-11-11 Merck & Co Inc Werkwijze ter bereiding van farmaceutische preparaten alsmede werkwijze ter bereiding van een aan een benzeenkern gesubstitueerd 1-methyl-4-(10,11-dihydro-5h-dibenzo (a,d)cyclohepten-5-ylideen)-piperidinederivaat.
US4076714A (en) * 1974-11-25 1978-02-28 Merck & Co., Inc. 1-Methyl-4-(2-carboxy-thioxanthen-9-ylidene)-piperidine an appetite stimulant and antihistaminic agent
US4160031A (en) * 1975-03-28 1979-07-03 Merck & Co., Inc. Antihistaminic and appetite stimulating 10,11-dihydro-3-carboxycyproheptadine
US4066772A (en) * 1975-07-21 1978-01-03 Janssen Pharmaceutica N.V. 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds

Also Published As

Publication number Publication date
CA1203798A (en) 1986-04-29
IE830833L (en) 1983-10-14
DK161983D0 (da) 1983-04-13
IE55033B1 (en) 1990-05-09
JPS58188879A (ja) 1983-11-04
EP0092114A2 (de) 1983-10-26
EP0092114A3 (en) 1985-01-16
ES8404686A1 (es) 1984-05-16
PT76501A (en) 1983-05-01
US4412999A (en) 1983-11-01
DE3374312D1 (en) 1987-12-10
ZA832589B (en) 1984-11-28
GR78832B (de) 1984-10-02
KR840004422A (ko) 1984-10-15
IL68306A (en) 1986-09-30
ES521359A0 (es) 1984-05-16
IL68306A0 (en) 1983-07-31
NZ203786A (en) 1985-11-08
AU1318883A (en) 1983-10-20
KR880002042B1 (ko) 1988-10-13
DK161983A (da) 1983-10-15
EP0092114B1 (de) 1987-11-04
AU556530B2 (en) 1986-11-06
PT76501B (en) 1986-02-06

Similar Documents

Publication Publication Date Title
DE69736812T2 (de) Neue integrin rezeptor antagonisten
NO1994011I1 (no) Cisaprid
ATE30589T1 (de) Ester von cyproheptadin-3-carbonsaeure und verbindungen, die eine aehnliche struktur aufweisen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE256468T1 (de) Behandlung von nicht-entzündlichen darmerkrankungen
SE8307119L (sv) Karboxylsyraamider och derivat derav
FI884375A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-(1-alkyyli-3-hydroksi-4-piperidinyyli)bentsamidien valmistamiseksi
GB1083193A (en) Guanidine derivatives and process for their manufacture
ES464146A1 (es) Procedimiento de preparacion de derivados de la piperidina.
PT86427B (pt) Processo para a preparacao de derivados de piperidina
ATE148466T1 (de) Cinnolin-3-carbonsäurederivate als 5-ht3- antagonisten
RU94020400A (ru) Производные индола, способ их получения, фармацевтическая композиция, способ лечения головной боли
EP0024309A3 (de) Triazolopyridazinderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende Arzneimittel
FI103116B1 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten, N-substituoitujen atsaheterosyklisten karboksyylihappojohdannaisten valmistamiseksi
DE69206607T2 (de) Behandlung von kognitiven störungen.
DK447387A (da) Hexahydroarylquinolizinforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
ATE19777T1 (de) Pyridobenzodiazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
SU400592A1 (ru) СПОСОБ ПОЛУЧЕНИЯ ДИАРИЛБЕНЗОДИИЗОКСАЗОЛДИОКОВИзобретение относитс к 'Новому способу получени диарилбензодиизоксазолдионов, примен ющихс в качестве лекарственных препаратов, фотосенсибилизаторов, ингибиторов коррозии и т. д.Известен способ получени диарилбензодиизоксазолдионов общей формулы I
ES419587A1 (es) Procedimiento para la preparacion de composiciones de apli- cacion en veterinaria.
FR2340952A1 (fr) Procede de preparation d'un alcaloide de type di-indol ou ses sels d'additions avec un acide, pharmaceutiquement actifs, ainsi que des compositions pharmaceutiques le contenant
GB1148074A (en) 2-alkyl-3-(4'-amino-phenyl)-3h-4-quinazolones
GB1054539A (de)
TH2751A (th) กรรมวิธีการเตรียมอนุพันธ์ n-(4-พิเพอริดินิน) ไบไซคลิคคอนเดนส์ 2-อิมิดาโซลแอมีน
GB900352A (en) Dextro- and laevo-rotatory 5-(3-dimethylamino-2-methylpropyl)iminodibenzyl
JPS5273864A (en) Preparation of novel carboxylic acid amide derivative
RU93044977A (ru) Ароматические производные аминов и способ их получения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee